Video-assisted mediastinoscopic lymphadenectomy is associated with better survival than mediastinoscopy in patients with resected non–small cell lung.

Slides:

Advertisements

Similar presentations

Surgical Treatment and Prognosis of Primitive Neuroectodermal Tumors of the Thorax Adalet Demir, MD, Mehmet Zeki Gunluoglu, MD, Nergiz Dagoglu, MD, Akif.

Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer? Traves D. Crabtree, MD, Varun Puri,

Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than.

Lung cancer screening: No more excuses

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Ground glass opacity of the lung: The veil that needs lifting

Survival after resection of synchronous non–small cell lung cancer

Intrinsic cardiac stem cells are essential for regeneration

Joshua E. Rosen, BASc, Michelle C

William M. DeCampli, MD, PhD

The Journal of Thoracic and Cardiovascular Surgery

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial Stacey.

Go on-pump or off-pump in diabetic patients?

Propensity score–matched analysis of adjuvant chemotherapy for stage I non–small cell lung cancer Yasuhiro Tsutani, MD, PhD, Yoshihiro Miyata, MD, PhD,

The lord of the rings Antonio Miceli, MD, PhD

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

Is tissue the issue? Brian E. Louie, MD, MHA, MPH, FRCSC, FACS

Treatment trends in early-stage lung cancer in the United States, 2004 to 2013: A time- trend analysis of the National Cancer Data Base Kathryn E. Engelhardt,

Yang Zhang, MD, Haiquan Chen, MD, PhD

Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non- Small Cell Lung Cancer Adalet Demir, MD, Akif Turna, MD, PhD, FETCS,

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Innovation and science: The future of valve design

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

A first start for lung transplantation?

Stephen R. Broderick, MD, MPHS

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Are discordant positron emission tomography and pathological assessments of the mediastinum in non–small cell lung cancer significant? Daniel J. Tandberg,

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Manuel J. Antunes, MD, PhD, DSc

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Development of a patient-centered aggregate score to predict survival after lung resection for non–small cell lung cancer Alessandro Brunelli, MD, Michele.

Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease? Mara B. Antonoff,

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Linda W. Martin, MD, MPH, FCCP, FACS, Gail E

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD

“The more things change…”: The challenges ahead

Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker Adnan Sayar,

Toward a more rational approach in treating type B aortic dissection

Aritoshi Hattori, MD, Kenji Suzuki, MD

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

Energized lung resections

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Salvage surgery for advanced non–small cell lung cancer after response to gefitinib Tomoyuki Hishida, MD, Kanji Nagai, MD, Tetsuya Mitsudomi, MD, Kohei.

Who should decide margin length in pulmonary excision of lung cancer?

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

How do we follow up our patients

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W

Presentation transcript:

Video-assisted mediastinoscopic lymphadenectomy is associated with better survival than mediastinoscopy in patients with resected non–small cell lung cancer Akif Turna, MD, PhD, FETCS, Ahmet Demirkaya, MD, Serkan Özkul, MD, Buge Oz, MD, Atilla Gurses, MD, Kamil Kaynak, MD, FETCS The Journal of Thoracic and Cardiovascular Surgery Volume 146, Issue 4, Pages 774-780 (October 2013) DOI: 10.1016/j.jtcvs.2013.04.036 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 CONSORT 2010 diagram of the study. VAMLA, Video-assisted mediastinoscopic lymphadenectomy. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 774-780DOI: (10.1016/j.jtcvs.2013.04.036) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Survival curves of patients who underwent video-assisted mediastinoscopic lymphadenectomy (VAMLA) or standard mediastinoscopy. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 774-780DOI: (10.1016/j.jtcvs.2013.04.036) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Survival curves of propensity-matched non–small cell lung cancer patients (n = 50) who underwent either video-assisted mediastinoscopic lymphadenectomy (VAMLA) or standard mediastinoscopy. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 774-780DOI: (10.1016/j.jtcvs.2013.04.036) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions